Author(s): Yancey-Wrona JE, Raymond TJ, Mercer HK, Sadee W, Bilsky EJ
Aims: The current studies were designed to compare the in vivo potencies of the opioid antagonists 6beta-naltrexol and naltrexone in blocking the effects of the opioid agonist hydrocodone following intravenous (i.v.) or oral (p.o.) administration.
Main methods: Adult male CD-1 mice were used for all experiments. The 55 degrees C tail-flick assay was used to assess the CNS antinociceptive activity of hydrocodone, and a charcoal meal gastrointestinal transit assay was used to assess the peripheral effects of hydrocodone. Graded antagonist dose-response curves for i.v. and p.o. 6beta-naltrexol and naltrexone were generated to determine ID(50) antagonist potency estimates against fixed doses of hydrocodone.
Key findings: Both antagonists produced dose-related blockade of hydrocodone-induced antinociception and inhibition of gastrointestinal transit. Naltrexone was between 5- and 13-fold more potent than 6beta-naltrexol in blocking a CNS effect of hydrocodone, whereas the drugs were nearly equipotent in blocking inhibition of gastrointestinal transit. Co-administration studies indicated an approximate 10-fold greater potency of 6beta-naltrexol for antagonism of hydrocodone-induced inhibition of gastrointestinal transit versus antinociception, whereas naltrexone blocked both effects with near equal potency. 6beta-naltrexol produced a longer duration of antagonist blockade and had a slower time to peak effect compared to naltrexone.
Significance: The pharmacology of 6beta-naltrexol differentiates it from currently available opioid antagonists. This includes an intermediate selectivity for peripheral versus central opioid receptors, a long duration of action, and neutral antagonist qualities in opioid exposed systems. These properties render it a drug candidate for a co-formulation product with opioid analgesics to reduce peripheral opioid side effects and limit abuse potential.
Referred From: https://www.ncbi.nlm.nih.gov/pubmed/19583969
Author(s): Gilson AM, Kreis PG
Author(s): Mendelson J, Flower K, Pletcher MJ, Galloway GP
Author(s): Zacny J, Bigelow G, Compton P, Foley K, Iguchi M, et al.
Author(s): Mendelson J, Jones RT
Author(s): Ko MC, Divin MF, Lee H, Woods JH, Traynor JR
Author(s): Li JX, McMahon LR, France CP
Author(s): Sirohi S, Dighe SV, Madia PA, Yoburn BC
Author(s): Divin MF, Holden Ko MC, Traynor JR
Author(s): Galloway GP, Koch M, Cello R, Smith DE
Author(s): Dunbar JL, Turncliff RZ, Dong Q, Silverman BL, Ehrich EW, et al.
Author(s): Thomas J, Karver S, Cooney GA, Chamberlain BH, Watt CK, et al.
Author(s): Kanof PD, Aronson MJ, Ness R, Cochrane KJ, Horvath TB, et al.